Use of artificial networks in clinical trials: A pilot study to predict responsiveness to donepezil in Alzheimer's disease

Journal of the American Geriatrics Society

Volumn 50, Issue 11, 2002, Pages 1857-1860

  Mecocci, Patrizia ^a   Grossi, Enzo ^b   Buscema, Massimo ^c   Intraligi, Marco ^c   Savarè, Rita ^b   Rinaldi, Patrizia ^a   Cherubini, Antonio ^a   Senin, Umberto ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Bracco Imaging SpA   (Italy)

^c Semeion centro ricerche di scienze della communicazione   (Italy)

Author keywords

Alzheimer's disease; Artificial neural network; Prediction; Responder; Treatment

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL;

ACCURACY; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ARTIFICIAL NEURAL NETWORK; CLINICAL TRIAL; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PREDICTION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; CLINICAL TRIALS; DISCRIMINANT ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INDANS; MALE; MIDDLE AGED; NEURAL NETWORKS (COMPUTER); PILOT PROJECTS; PIPERIDINES; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 0036843749     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2002.50516.x     Document Type: Article

References (23)

1. Mayeux R, Sano M. Treatment of Alzheimer's disease. N Engl J Med 1999;341:1670-1679.
2. Knopman D, Schneider L, Davis K et al. Long-term tacrine (Cognex) treatment. Effects on nursing home placement and mortality. Tacrine Study Group. Neurology 1996;47:166-177.
3. Rogers SL, Farlow MR, Doody RS et al. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology 1998;50:136-145.
4. Rösler M, Anand R, Cicin-Sain A et al. Efficacy and salety of rivastigmine in patients with Alzheimer's disease: International randomised controlled trial. BMJ 1999;318:633-638.
5. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry I994;141:1356-1364.
6. Knopman DS, Knapp MJ, Gracon SI. The clinician interview based impression (CIBI): A clinician's global change rating scale in Alzheimer's disease. Neurology 1994;44:2315-2321.
7. Cross SS, Harrison RF, Kennedy RL. Introduction to neural networks. Lancet 1995;346:1075-1079.
8. Baxt WG. Application of artificial neural networks to clinical medicine. Lancet 1995;346:1135-1138.
9. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975;12:189-198.
10. McKhann G, Drachman D, Folstein M et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRD, a work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
11. Reisberg B, Ferris SH, deLeon MJ et al. The global deterioration scale for assessent of primary degenerative dementia. Am J Psychiatry 1982;139:1136-1139.
12. Rumelhart DE, McClelland JL. Parallel Distributed Processing. Cambridge, MA: The MIT Press, 1986.
13. Buscema M, Sacco P. Feed Forward Networks in Financial Prediction: The Future That Modifies the Present. Rome, Italy: Expert: Systems, 2000.
14. Buscema M. Sine Net. A New Learning Rule for Adaptive Systems (Semeion Technical Paper 2l). Rome, Italy: Semeion, 2000.
15. Buscema M. Artificial neural networks and complex social systems. Subst Use Misuse 1998;33:495-501.
16. Buscema M. Semeion Group. Artificial Neural Networks and Complex Social Systems. Milan, Italy: Franco Angeli Publisher, 1999.
17. Poirier J, Delisle MC, Quirion R et al. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer's disease. Proc Natl Acad Sci U S A 1995;92:12260-12264.
18. Farlow MR, Cyrus PA, Nadel A et al. Metrifonate treatment of AD: Influence of APOE genotype. Neurology 1999;53:2010-2016.
19. Parbhane RV, Tambe SS, Kulkarni BD. ANN modeling of DNA sequences: New strategies using DNA shape code. Comput Chem 2000;24:699-711.
20. Jagla B, Schuchhardt J. Adaptive encoding neural networks for the recognition of human signal peptide cleavage site. Bioinformatics 2000;16:245-250.
21. Politi E, Balduzzi C, Bussi R et al. Artificial neural network: A study in clinical psychopharmacology, Psychiatry Res 1999;87:203-215
22. Massini G, Shabtay L. Use of a constraint satisfaction network model for the evaluation of the methadone treatments of drug addicts. Subst Use Misuse 1998;33:625-656.
23. Tafeit E, Reibnegger G. Artificial neural networks in laboratory medicine and medical outcome prediction. Clin Chem Lab Med 1999;37:845-853.